Plasma-SELEX for Acute Myocardial Infarction Biomarker Discovery and Diagnosis
Analytical Chemistry · 28.07.2026 · 98 (29) · 21333-21343
DOI: 10.1021/acs.analchem.6c01367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 14.07.2026. Verfasst von Xianying Liao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Medicine (IMM), Department of Cardiology, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 160 P…. Hauptthemen laut MEDLINE: Myocardial Infarction, SELEX Aptamer Technique, Malate Dehydrogenase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Innovative Research Team of High-level Local University in Shanghai, National Natural Science Foundation of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
Early diagnosis of acute diseases is fundamentally constrained by the lack of chemically tractable methods for biomarker discovery directly from a complex plasma. Here, we report PSABD (plasma-SELEX-enriched aptamer-based biomarker discovery and diagnosis), a chemical platform that integrates carboxylate magnetic-bead-mediated plasma protein capture within situ aptamer SELEX, enabling molecular-recognition-driven identification of disease-associated biomarkers. With this strategy, enriched aptamers not only serve as affinity probes but also function as structurally programmable molecular handles to pull down their targets, thereby linking selection chemistry with proteomic discovery. With acute myocardial infarction (AMI) as a model, PSABD identified malate dehydrogenase 2 (MDH2) as an unexpected AMI-associated plasma protein, which was significantly elevated in AMI patient samples and exhibited a high binding affinity to selected aptamers. On the basis of this interaction, we developed an aptamer-based analytical platform capable of distinguishing AMI patients from healthy individuals. Collectively, PSABD establishes a general chemical strategy that bridges molecular recognition, biomarker discovery, and diagnostic development, highlighting aptamers as programmable chemical probes for the acute disease diagnosis and clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Medicine (IMM), Department of Cardiology, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd, Shanghai200127, China.
- Department of Cardiology, Renji Hospital Ningbo Branch, Shanghai Jiao Tong University School of Medicine, 1155 Binhai Second Road, Hangzhou Bay New District, Ningbo, Zhejiang315336, China.
- The Key Laboratory of Zhejiang Province for Aptamers and Theranostics, Zhejiang Cancer Hospital, Hangzhou, Institute of Medicine (HIM), Chinese Academy of SciencesHangzhou, Zhejiang, 310022, China.
ORCID-Profile: Yang Sun, Weihong Tan
Förderung
- Innovative Research Team of High-level Local University in Shanghai
- National Natural Science Foundation of China
- Chinese Academy of Sciences
- National Key Research and Development Program of China
Zitieren
APA
Liao, X., Chen, D., Huang, Z., Wang, S., Rong, J., Hu, L., Zhang, S., Qu, X., Xie, Y., Pu, J., Sun, Y., & Tan, W. (2026). Plasma-SELEX for Acute Myocardial Infarction Biomarker Discovery and Diagnosis. Analytical Chemistry, 98(29), 21333-21343. https://doi.org/10.1021/acs.analchem.6c01367
Vancouver
Liao X, Chen D, Huang Z, Wang S, Rong J, Hu L, et al. Plasma-SELEX for Acute Myocardial Infarction Biomarker Discovery and Diagnosis. Analytical Chemistry. 2026;98(29):21333-21343. doi:10.1021/acs.analchem.6c01367
BibTeX
@article{Liao2026,
author = {Liao, Xianying and Chen, Daiquan and Huang, Zichen and Wang, Shanshan and Rong, Jiacheng and Hu, Li and Zhang, Sheng and Qu, Xiaolong and Xie, Yuquan and Pu, Jun and Sun, Yang and Tan, Weihong},
title = {Plasma-SELEX for Acute Myocardial Infarction Biomarker Discovery and Diagnosis},
journal = {Analytical Chemistry},
year = {2026},
volume = {98},
number = {29},
pages = {21333--21343},
doi = {10.1021/acs.analchem.6c01367}
}
EUVIMED